Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Loxo Oncology CS (LOXO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 1,912,349
  • Shares Outstanding, K 26,150
  • Annual Sales, $ 0 K
  • Annual Income, $ -72,400 K
  • 36-Month Beta 2.90
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 8.10

Price Performance

See More
Period Period Low Period High Performance
1-Month
71.75 +2.30%
on 07/19/17
82.99 -11.56%
on 06/30/17
-6.77 (-8.44%)
since 06/23/17
3-Month
42.11 +74.30%
on 05/09/17
83.12 -11.69%
on 06/22/17
+25.11 (+52.00%)
since 04/25/17
52-Week
17.14 +328.24%
on 11/03/16
83.12 -11.69%
on 06/22/17
+48.33 (+192.78%)
since 07/25/16

Most Recent Stories

More News
Loxo Oncology In Shares Up 53.3% Since SmarTrend's Buy Recommendation (LOXO)

SmarTrend identified an Uptrend for Loxo Oncology In (NASDAQ:LOXO) on May 23rd, 2017 at $48.71. In approximately 2 months, Loxo Oncology In has returned 53.31% as of today's recent price of $74.67.

LOXO : 73.29 (-1.32%)
Shares of LOXO Up 57.3% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Loxo Oncology In (NASDAQ:LOXO) on May 23rd, 2017 at $48.71. In approximately 1 month, Loxo Oncology In has returned 57.33% as of today's recent price of $76.63.

LOXO : 73.29 (-1.32%)
Look for Shares of Loxo Oncology In to Potentially Pullback after Yesterday's 3.72% Rise

Loxo Oncology In (NASDAQ:LOXO) traded in a range yesterday that spanned from a low of $76.00 to a high of $80.35. Yesterday, the shares gained 3.7%, which took the trading range above the 3-day high...

LOXO : 73.29 (-1.32%)
Loxo Oncology In Up 63.9% Since SmarTrend Uptrend Call (LOXO)

SmarTrend identified an Uptrend for Loxo Oncology In (NASDAQ:LOXO) on May 23rd, 2017 at $48.71. In approximately 1 month, Loxo Oncology In has returned 63.90% as of today's recent price of $79.83.

LOXO : 73.29 (-1.32%)
Loxo Oncology Announces the Closing of its Follow-On Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced the closing of its...

MS : 47.65 (+2.01%)
LOXO : 73.29 (-1.32%)
Loxo Oncology Prices Follow-On Offering of Common Stock

Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced the pricing of its...

LOXO : 73.29 (-1.32%)
Loxo Oncology Announces Proposed Public Offering of Common Stock

Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, announced today that it intends to...

MS : 47.65 (+2.01%)
LOXO : 73.29 (-1.32%)
Herbalife and CVS slip while Gigamon and State Street climb

NEW YORK (AP) — Stocks that moved substantially or traded heavily on Monday:

OXY : 61.04 (+2.74%)
STT : 92.38 (+0.93%)
HLF : 69.47 (+0.49%)
GIMO : 39.45 (+0.51%)
FOR : 17.15 (+0.59%)
LOXO : 73.29 (-1.32%)
MAC : 59.08 (+1.25%)
Loxo Oncology Announces Clinical Proof of Concept Publication for Next-Generation TRK Inhibitor LOXO-195

Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced the online publication...

LOXO : 73.29 (-1.32%)
Loxo Oncology Breakthrough Therapy Larotrectinib Demonstrates 76 Percent Confirmed Objective Response Rate in TRK Fusion Adult and Pediatric Cancers as Presented at the American Society of Clinical Oncology Annual Meeting

- Responses to Selective TRK Inhibitor Observed Across Tumor Types Harboring TRK Fusions -

LOXO : 73.29 (-1.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Loxo Oncology, Inc. is a biopharmaceutical company. It develops targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Loxo Oncology, Inc. is headquartered in Stamford, Connecticut.

See More

Support & Resistance

2nd Resistance Point 76.42
1st Resistance Point 75.35
Last Price 73.29
1st Support Level 73.03
2nd Support Level 71.78

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.